AccessMyLibrary provides FREE access to millions of articles from top publications available through your library.
Close
Create a link to this page
Copy and paste this link tag into your Web page or blog:
<a href="http://www.accessmylibrary.com/coms2/summary_0286-30251649_ITM" title="Facts and information about Johnson & Johnson to launch new schizophrenia drug.(Business)(paliperidone)(Brief article)">Johnson & Johnson to launch new schizophrenia drug.(Business)(paliperidone)(Brief article)</a>
Close
Set up an RSS feed that alerts you when new articles from Mental Health Weekly are available.
Frequently asked questions about RSS feeds
Johnson & Johnson to launch new schizophrenia drug.(Business)(paliperidone)(Brief article)
Johnson & Johnson Pharmaceutical Research and Development, L.L.C. announced (Sept. 29) that it has received an approvable letter from the Food and Drug Administration (FDA) for its new drug formulation paliperidone extended release (ER) tablets for the treatment of schizophrenia. The company writes that it will work quickly to resolve the FDA's questions toward earning final FDA …
Related articles from newspapers, magazines, journals, and more
-
- Agency licenses Johnson & Johnson/Chiron hepatitis C virus test. (Ortho HCV...
-
Newspaper article from: AIDS Weekly
March 23, 1992
700+ words
-
- DCGI MAY ASK J and J TO SUBMIT CLINICAL DATA TO SUBSTANTIATE `BABY' CLAIM...
-
News wire article from: Asia Africa Intelligence Wire
May 12, 2005
700+ words
-
- Shares of Johnson & Johnson. (Financials).(drop after news of non-approvable...
-
Magazine article from: Drug Store News
July 3, 2002
700+ words
-
- FDA fails to reduce accessibility of paracetamol despite 450 deaths a year:...
-
Magazine article from: British Medical Journal
Moynihan, Ray
September 28, 2002
700+ words
-
- Handmaiden.(Food and Drug Administration)(Editorial)
-
Magazine article from: Drug & Cosmetic Industry
Davis, Donald A.
September 1, 1996
700+ words
